Castleview Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-438
| Closed | -$78.6K | – | 177 |
|
|
2024
Q4 | $78.6K | Buy |
438
+61
| +16% | +$10.9K | 0.04% | 283 |
|
|
2024
Q3 | $74.5K | Sell |
377
-25
| -6% | -$4.94K | 0.04% | 271 |
|
|
2024
Q2 | $69K | Sell |
402
-82
| -17% | -$14.1K | 0.04% | 284 |
|
|
2024
Q1 | $88.1K | Buy |
484
+2
| +0.4% | +$364 | 0.05% | 274 |
|
|
2023
Q4 | $74.7K | Buy |
482
+202
| +72% | +$31.3K | 0.05% | 238 |
|
|
2023
Q3 | $41.7K | Sell |
280
-66
| -19% | -$9.84K | 0.04% | 277 |
|
|
2023
Q2 | $46.6K | Buy |
346
+21
| +6% | +$2.83K | 0.04% | 259 |
|
|
2023
Q1 | $51.8K | Buy |
325
+2
| +0.6% | +$318 | 0.05% | 261 |
|
|
2022
Q4 | $52.1K | Buy |
323
+195
| +152% | +$31.5K | 0.05% | 226 |
|
|
2022
Q3 | $17K | Buy |
128
+73
| +133% | +$9.7K | 0.02% | 332 |
|
|
2022
Q2 | $4.57K | Sell |
55
-1,845
| -97% | -$153K | ﹤0.01% | 554 |
|
|
2022
Q1 | $308K | Sell |
1,900
-1,228,438
| -100% | -$199M | 0.19% | 113 |
|
|
2021
Q4 | $9.09K | Buy |
+1,230,338
| New | +$9.09K | 0.07% | 99 |
|
|
2021
Q2 | $1.14M | Buy |
+10,117
| New | +$1.14M | 0.5% | 41 |
|
|
2018
Q1 | $562K | Buy |
+5,934
| New | +$562K | 0.46% | 51 |
|